182 related articles for article (PubMed ID: 29035547)
1. Pharmacokinetics and Pharmacodynamics of the Triterpenoid Ursolic Acid in Regulating the Antioxidant, Anti-inflammatory, and Epigenetic Gene Responses in Rat Leukocytes.
Zhang C; Wang C; Li W; Wu R; Guo Y; Cheng D; Yang Y; Androulakis IP; Kong AN
Mol Pharm; 2017 Nov; 14(11):3709-3717. PubMed ID: 29035547
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics and Pharmacodynamics of Curcumin in regulating anti-inflammatory and epigenetic gene expression.
Boyanapalli SSS; Huang Y; Su Z; Cheng D; Zhang C; Guo Y; Rao R; Androulakis IP; Kong AN
Biopharm Drug Dispos; 2018 Jun; 39(6):289-297. PubMed ID: 29870054
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics and pharmacodynamics of phase II drug metabolizing/antioxidant enzymes gene response by anticancer agent sulforaphane in rat lymphocytes.
Wang H; Khor TO; Yang Q; Huang Y; Wu TY; Saw CL; Lin W; Androulakis IP; Kong AN
Mol Pharm; 2012 Oct; 9(10):2819-27. PubMed ID: 22931102
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics, Pharmacodynamics, and PKPD Modeling of Curcumin in Regulating Antioxidant and Epigenetic Gene Expression in Healthy Human Volunteers.
Cheng D; Li W; Wang L; Lin T; Poiani G; Wassef A; Hudlikar R; Ondar P; Brunetti L; Kong AN
Mol Pharm; 2019 May; 16(5):1881-1889. PubMed ID: 30860383
[TBL] [Abstract][Full Text] [Related]
5. Epigenetic modifications of triterpenoid ursolic acid in activating Nrf2 and blocking cellular transformation of mouse epidermal cells.
Kim H; Ramirez CN; Su ZY; Kong AN
J Nutr Biochem; 2016 Jul; 33():54-62. PubMed ID: 27260468
[TBL] [Abstract][Full Text] [Related]
6. Ursolic acid: A systematic review of its pharmacology, toxicity and rethink on its pharmacokinetics based on PK-PD model.
Sun Q; He M; Zhang M; Zeng S; Chen L; Zhou L; Xu H
Fitoterapia; 2020 Nov; 147():104735. PubMed ID: 33010369
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics and pharmacodynamics of 3,3'-diindolylmethane (DIM) in regulating gene expression of phase II drug metabolizing enzymes.
Wu TY; Huang Y; Zhang C; Su ZY; Boyanapalli S; Khor TO; Wang H; Lin H; Gounder M; Kagan L; Androulakis IP; Kong AN
J Pharmacokinet Pharmacodyn; 2015 Aug; 42(4):401-8. PubMed ID: 26138223
[TBL] [Abstract][Full Text] [Related]
8. Ursolic acid ameliorates hypobaric hypoxia-induced skeletal muscle protein loss via upregulating Akt pathway: An experimental study using rat model.
Rathor R; Agrawal A; Kumar R; Suryakumar G; Singh SN
IUBMB Life; 2021 Feb; 73(2):375-389. PubMed ID: 33368975
[TBL] [Abstract][Full Text] [Related]
9. Effect of ursolic acid in attenuating chronic constriction injury-induced neuropathic pain in rats.
Bhat RA; Lingaraju MC; Pathak NN; Kalra J; Kumar D; Kumar D; Tandan SK
Fundam Clin Pharmacol; 2016 Dec; 30(6):517-528. PubMed ID: 27414466
[TBL] [Abstract][Full Text] [Related]
10. Triterpenoid ursolic acid drives metabolic rewiring and epigenetic reprogramming in treatment/prevention of human prostate cancer.
Li S; Wu R; Wang L; Dina Kuo HC; Sargsyan D; Zheng X; Wang Y; Su X; Kong AN
Mol Carcinog; 2022 Jan; 61(1):111-121. PubMed ID: 34727410
[TBL] [Abstract][Full Text] [Related]
11. Anti-inflammatory potential of ursolic acid in Mycobacterium tuberculosis-sensitized and concanavalin A-stimulated cells.
Zerin T; Lee M; Jang WS; Nam KW; Song HY
Mol Med Rep; 2016 Mar; 13(3):2736-44. PubMed ID: 26847129
[TBL] [Abstract][Full Text] [Related]
12. Ursolic acid ameliorates carbon tetrachloride-induced oxidative DNA damage and inflammation in mouse kidney by inhibiting the STAT3 and NF-κB activities.
Ma JQ; Ding J; Xiao ZH; Liu CM
Int Immunopharmacol; 2014 Aug; 21(2):389-95. PubMed ID: 24880019
[TBL] [Abstract][Full Text] [Related]
13. Ursolic acid protects mouse liver against CCl4-induced oxidative stress and inflammation by the MAPK/NF-κB pathway.
Ma JQ; Ding J; Zhang L; Liu CM
Environ Toxicol Pharmacol; 2014 May; 37(3):975-83. PubMed ID: 24727148
[TBL] [Abstract][Full Text] [Related]
14. Ursolic acid prevents augmented peripheral inflammation and inflammatory hyperalgesia in high-fat diet-induced obese rats by restoring downregulated spinal PPARα.
Zhang Y; Song C; Li H; Hou J; Li D
Mol Med Rep; 2016 Jun; 13(6):5309-16. PubMed ID: 27108888
[TBL] [Abstract][Full Text] [Related]
15. Ursolic acid attenuates lipopolysaccharide-induced cognitive deficits in mouse brain through suppressing p38/NF-κB mediated inflammatory pathways.
Wang YJ; Lu J; Wu DM; Zheng ZH; Zheng YL; Wang XH; Ruan J; Sun X; Shan Q; Zhang ZF
Neurobiol Learn Mem; 2011 Sep; 96(2):156-65. PubMed ID: 21496491
[TBL] [Abstract][Full Text] [Related]
16. PTEN-knockout regulates metabolic rewiring and epigenetic reprogramming in prostate cancer and chemoprevention by triterpenoid ursolic acid.
Wang L; Wang C; Sarwar MS; Chou P; Wang Y; Su X; Kong AT
FASEB J; 2022 Nov; 36(11):e22626. PubMed ID: 36305462
[TBL] [Abstract][Full Text] [Related]
17. Ursolic acid inhibits nuclear factor-κB signaling in intestinal epithelial cells and macrophages, and attenuates experimental colitis in mice.
Chun J; Lee C; Hwang SW; Im JP; Kim JS
Life Sci; 2014 Aug; 110(1):23-34. PubMed ID: 24992474
[TBL] [Abstract][Full Text] [Related]
18. Ursolic acid and oleanolic acid, members of pentacyclic triterpenoid acids, suppress TNF-α-induced E-selectin expression by cultured umbilical vein endothelial cells.
Takada K; Nakane T; Masuda K; Ishii H
Phytomedicine; 2010 Dec; 17(14):1114-9. PubMed ID: 20579861
[TBL] [Abstract][Full Text] [Related]
19. Ursolic acid inhibits tumor angiogenesis and induces apoptosis through mitochondrial-dependent pathway in Ehrlich ascites carcinoma tumor.
Saraswati S; Agrawal SS; Alhaider AA
Chem Biol Interact; 2013 Nov; 206(2):153-65. PubMed ID: 24051192
[TBL] [Abstract][Full Text] [Related]
20. The anti-arthritic effect of ursolic acid on zymosan-induced acute inflammation and adjuvant-induced chronic arthritis models.
Kang SY; Yoon SY; Roh DH; Jeon MJ; Seo HS; Uh DK; Kwon YB; Kim HW; Han HJ; Lee HJ; Lee JH
J Pharm Pharmacol; 2008 Oct; 60(10):1347-54. PubMed ID: 18812028
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
